Advertisement
Advertisement

BDSX

BDSX logo

Biodesix, Inc. Common Stock

18.67
USD
Sponsored
-0.49
-2.56%
Jun 24, 16:00 UTC -4
Closed
exchange

Pre-Market

19.81

+1.14
+6.11%

BDSX Earnings Reports

Positive Surprise Ratio

BDSX beat 15 of 23 last estimates.

65%

Next Report

Date of Next Report
Aug 05, 2026
Estimate for Q2 26 (Revenue/ EPS)
$26.48M
/
-$0.91
Implied change from Q1 26 (Revenue/ EPS)
+3.63%
/
+12.35%
Implied change from Q2 25 (Revenue/ EPS)
+32.29%
/
-43.13%

Biodesix, Inc. Common Stock earnings per share and revenue

On May 04, 2026, BDSX reported earnings of -0.81 USD per share (EPS) for Q1 26, beating the estimate of -1.11 USD, resulting in a 27.54% surprise. Revenue reached 25.55 million, compared to an expected 23.64 million, with a 8.09% difference. The market reacted with a +32.56% price change (close before vs. close after earnings).
Looking ahead to Q2 26, 5 analysts forecast an EPS of -0.91 USD, with revenue projected to reach 26.48 million USD, implying an increase of 12.35% EPS, and increase of 3.63% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
INVO Fertility, Inc. Common Stock
Report Date
Jun 22, 2026 For Q1 26
Estimate
-$1.26
Actual
-$3.38
Surprise
-167.72%
FAQ
For Q1 2026, Biodesix, Inc. Common Stock reported EPS of -$0.81, beating estimates by 27.54%, and revenue of $25.55M, 8.09% above expectations.
The stock price moved up 32.56%, changed from $11.27 before the earnings release to $14.94 the day after.
The next earning report is scheduled for Aug 05, 2026.
Based on 5 analysts, Biodesix, Inc. Common Stock is expected to report EPS of -$0.91 and revenue of $26.48M for Q2 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement